Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shanghai - Delayed Quote CNY

Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (688266.SS)

Compare
100.02
-5.75
(-5.44%)
At close: 3:00:01 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Mr. Zelin Sheng Chairman of the Board & GM -- -- 1960
Mr. Gang Huang CFO & Deputy GM -- -- 1971
Ms. Zeqi Sheng Chief Scientific Officer -- -- 1964
Ms. Huiping Lu Executive VP & Director -- -- 1967
Mr. Jisheng Wu Director & Deputy GM -- -- 1965
Mr. Binhua Lv Deputy General Manager & Director -- -- 1979
Ms. Qingping Gao Deputy GM & Board Secretary -- -- 1977
Shice Shao Accounting Supervisor -- -- --

Suzhou Zelgen Biopharmaceuticals Co.,Ltd.

No. 209, Chenfeng Road
Kunshan, 215300
China
86 512 5701 8310 https://www.zelgen.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Suzhou Zelgen Biopharmaceuticals Co.,Ltd. researches and develops, manufactures, and sells medicines in the People's Republic of China. It offers donafenib tablets; recombinant human thrombin for topincal use; jacktinib tablets; and recombinant human thyroid-stimulating hormone for injection; obeticholic acid magnesium tablets; ZG19018 tablets; ZG005 powder for injection; and alkotinib capsules for the treatment of liver cancer, non-small cell lung cancer, small cell lung cancer, colorectal cancer, thyroid cancer, and neuroendocrine cancer, as well as multiple therapeutic areas, such as bleeding, hepatobiliary diseases, and autoimmune diseases. The company was founded in 2009 and is based in Kunshan, the People's Republic of China.

Corporate Governance

Suzhou Zelgen Biopharmaceuticals Co.,Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers